DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Voltaren-XR (Diclofenac Sodium Extended Release) - Summary

 
 



VOLTAREN-XR SUMMARY

Voltaren® -XR, (diclofenac sodium extended-release tablets), is a benzeneacetic acid derivative. Voltaren-XR is available as Extended-Release Tablets of 100 mg (light pink) for oral administration.

Voltaren® -XR (diclofenac sodium extended-release tablets) is indicated:

  • For relief of signs and symptoms of osteoarthritis
  • For relief of signs and symptoms of rheumatoid arthritis


See all Voltaren-XR indications & dosage >>

NEWS HIGHLIGHTS

Published Studies Related to Voltaren-XR (Diclofenac Extended Release)

Economic analysis of celecoxib versus diclofenac plus omeprazole for the treatment of arthritis in patients at risk of ulcer disease. [2003.07.15]
AIM: To evaluate the economic impact of celecoxib therapy vs. diclofenac plus omeprazole therapy for the treatment of arthritis in Chinese patients with a high risk of bleeding, from the perspective of a public health organization in Hong Kong... CONCLUSIONS: Celecoxib therapy appears to cost less compared with diclofenac plus omeprazole for treatment of arthritis in Chinese patients with a high risk of bleeding.

Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. [2003.06]
BACKGROUND & AIMS: Acute pancreatitis following endoscopic retrograde cholangiopancreatography presents a unique opportunity for prophylaxis and early modification of the disease process because the initial triggering event is temporally well defined and takes place in the hospital. We report a prospective, single-center, randomized, double-blind controlled trial to determine if rectal diclofenac reduces the incidence of pancreatitis following cholangiopancreatography... CONCLUSIONS: This trial shows that rectal diclofenac given immediately after endoscopic retrograde cholangiopancreatography can reduce the incidence of acute pancreatitis.

Efficacy of extended-release oral diclofenac in postoperative pain management after photorefractive keratectomy. [2013]
management of pain after PRK surgery... CONCLUSION: The results indicate that oral diclofenac (preoperatively) is more

Preparation and in vitro-in vivo evaluation of double layer coated and matrix sustained release pellet formulations of diclofenac potassium. [2011.03.15]
The purpose of the present study was to prepare matrix extended release pellets of diclofenac potassium using low amount of release-modifying agents and, to compare its performance in vivo with coated pellets and matrix tablets. Coated pellets were prepared by extrusion-spheronization, followed by double layer coating using different polymers separately...

Application of design of experiments and multilayer perceptrons neural network in the optimization of diclofenac sodium extended release tablets with Carbopol 71G. [2010.07]
The purpose of the study was to screen the effects of formulation factors on the in vitro release profile of diclofenac sodium from matrix tablets using design of experiment (DOE). Formulations of diclofenac sodium tablets, with Carbopol 71G as matrix substance, were optimized by artificial neural network...

more studies >>

Reports of Suspected Voltaren-XR (Diclofenac Extended Release) Side Effects

Rectal Perforation (3)Blood Pressure Increased (3)Vomiting (3)Muscular Weakness (3)Thrombosis (2)Drug Ineffective (2)Diverticulitis (2)Therapeutic Response Unexpected (2)Fatigue (2)Overdose (2)more >>


Page last updated: 2014-11-30

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015